Diphenidine also known as DPH is among new research chemicals that were created by research chemical manufacturers to learn more about NMDA receptor antagonists that act like an anesthetic chemical. Diphenidine is in the family of drugs known as diarylethylamine. The first mention of this research chemical was in 1924 which was used in laboratories and was used in 1956 to develop phencyclidine.
N-Ethyl-Hexedrone was mentioned with patent information in the 1960’s by Boehringer Ingelheim, however, the research chemical was not synthesized until 2011. The creation of N-Ethyl-Hexedrone helped create other compounds including methylenedioxpyrovalerone.
Methoxphenidine also known as MXP is found in the family of diarylethylamine research chemical.
There is not enough data available on methoxphenidine as a supplementary chemical for any medical use at this time and therefore it is not intended for human consumption. Manufacturers use synthetic substances to create analogs of medications that are listed as controlled substances to further help scientists perform experiments on similar research chemicals with the hopes of finding alternative compounds that will benefit humans with harsh or long term side effects.
4-Me-TMP was created by research chemical manufacturers as a supplementary chemical that may be used as an alternative to methylphenidate. However, at this time, it is only for usage in a controlled laboratory setting and is not intended for human consumption. With its close relationship to methylphenidate is shown some of the same effects seen in animal drug testing. However, 4-Me-TMP is not as effective at blocking the reuptake of dopamine even though it does have a high binding affinity.
Isopropylphenidate is a newly developed research chemical which is known to be a stimulant that has a peperidine base and is related to methylphenidate.
Most cathinone’s and other analogs such as 4-MC promotes the release of serotonin, norepinephrine, and dopamine. These analogs have been studied in vivo and in-vitro using lab rats. In the synaptosomes of the brain of rats, the results showed that 4-MC released serotonin, norepinephrine, and dopamine in the brains of rats, through transporters, SERT, NET, and DAT.
3-MeO-PCE first hit the market in 2010 and can be purchased from manufacturers of research chemicals to study this new supplementary compound. This chemical is in the arylcyclohexylamine family and is known to be a hallucinogenic dissociative. The chemical properties of 3-MeO-PCE are very closely related to 3-MeO-PCP.
Etizolam is listed with research chemicals in the family of diazepines known as thienotriazolodiazepines. The creation of research chemicals by qualified manufacturers allow scientists and other industries to learn more about the way specific chemicals work in a laboratory setting. Researchers in Italy published information regarding etizolam that states that these compounds used in the creation of etizolam is easy to oxidize, metabolizes fast, and is believed to have a lower risk of accumulation.
4-CEC is a research chemical in the cathinone family created from the Catha edulis plant. Research on this supplementary compound has not been thoroughly performed. The only data available is the chemical formula, the molecular mass, and the IUPAC name. However, it is closely related to cathine, methcathinone, and certain other amphetamines. These compounds created by research chemical manufacturers release dopamine and inhibit the reuptake of norepinephrine, epinephrine, and serotonin.
3-FPM is a research chemical obtainable from manufacturers that create research chemicals as well as supplementary chemicals. 3-FPM also referred to as Pal-593 is in the phenethylamine family and is known to be a stimulant. Via studies in laboratories as well as the chemistry of 3F-Phenmetrazine the effects are not as direct as other stimulants. The studies showed that 3-fpm produces less insomnia, euphoria, and nervousness than other chemicals in the same family.